PDIA5 and ARFIP1 as Immunogenetic Biomarkers and Therapeutic Targets in Pancreatic Neuroendocrine Neoplasms: A Multi-Omics Study Integrating MR, Gene Expression Microarray, and Single-Cell Transcriptomics

PDIA5 and ARFIP1 are promising biomarkers and therapeutic targets for PanNEN. Further validation and clinical exploration are required.

Authors

Huimin Guo (ORCID: https://orcid.org/0009-0007-0490-2289)
Qiang Jia (ORCID: https://orcid.org/0000-0001-6689-5255)
Shuzhan Yao
Zhaowei Meng (ORCID: https://orcid.org/0000-0002-4478-878X)
Jian Tan (ORCID: https://orcid.org/0000-0002-2914-0598)
Guobao Zheng

Institutions

Tianjin Medical University General Hospital (CN)
Shandong Provincial Hospital (CN)
Shandong First Medical University (CN)

Publication Details

Journal: Neuroendocrinology
Published: 2025-10-23
DOI: https://doi.org/10.1159/000548070
Citations: 1
Primary Topic: Neuroendocrine Tumor Research Advances
Type: article
Field-Weighted Citation Impact: 1.35

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

PDIA5 and ARFIP1 as Immunogenetic Biomarkers and Therapeutic Targets in Pancreatic Neuroendocrine Neoplasms: A Multi-Omics Study Integrating MR, Gene Expression Microarray, and Single-Cell Transcriptomics

Huimin Guo, Qiang Jia, Shuzhan Yao, Zhaowei Meng et al.

Oct 23, 2025

1 citations

Neuroendocrinology

Neuroendocrine Tumor Research Advances

1.35

article

PDIA5 and ARFIP1 as Immunogenetic Biomarkers and Therapeutic Targets in Pancreatic Neuroendocrine Neoplasms: A Multi-Omics Study Integrating MR, Gene Expression Microarray, and Single-Cell Transcriptomics

Huimin Guo, Qiang Jia, Shuzhan Yao, Zhaowei Meng, Jian Tan, Guobao Zheng

October 23, 2025article en

1 citations

Abstract

PDIA5 and ARFIP1 are promising biomarkers and therapeutic targets for PanNEN. Further validation and clinical exploration are required.

NeuroendocrinologyVol. 115(10-11)

Tianjin Medical University General Hospital (CN), Shandong Provincial Hospital (CN), Shandong First Medical University (CN)

Openalex Percentile: Top 14%

Neuroendocrine Tumor Research Advances

1.35

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

PDIA5 and ARFIP1 as Immunogenetic Biomarkers and Therapeutic Targets in Pancreatic Neuroendocrine Neoplasms: A Multi-Omics Study Integrating MR, Gene Expression Microarray, and Single-Cell Transcriptomics — Huimin Guo, Qiang Jia, et al. · Neuroendocrinology (2025) | TGRS Research Map | TGRS